💊

Prescription Drugs

💊 Drugs • 11,927 recalls

Ranitidine Syrup Oral Solution 15 mg/mL 6. fl. oz. (473 mL), NDC 65162-664-90.

Amneal Pharmaceuticals

Class I - Dangerous

CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API

Nov 22, 2019 Prescription Drugs View Details →

fentaNYL 2000 mcg/100 mL (20 mcg/mL) in 0.9% Sodium Chloride, 100 mL Bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1094-36

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's: 0597-0120-06, 0597-0120-08, 0597-0120-09, 0597-0120-24, 0597-0120-38, 0597-0120-50, 0597-0120-76, 0597-0120-78, 0597-0120-80, 0597-0120-82, 0597-0120-87.

Sanofi-Aventis U.S.

Class I - Dangerous

CGMP Deviations: Presence of NDMA impurity detected in product.

Oct 22, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 2750 mcg/55 mL (50 mcg/mL) 55 mL Syringe, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1100-50

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 2500 mcg/50 mL (50 mcg/mL) 50 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1436-76

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride 100 mL CADD, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478NDC 70092-1259-75

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 1250 mcg/250 mL (5 mcg/mL) in 0.9% Sodium Chloride 250 mL Bag Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1444-05

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

EXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, Rx only, Manufactured by: Pacira Pharmaceuticals, Inc. San Diego, CA 92121. NDC: 65250-266-20,

Pacira Pharmaceuticals

Class I - Dangerous

Sub Potent Drug: Out of Specification (OOS)

Nov 21, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 200 mcg/100 mL (2 mcg/mL) ROPivacaine HCl 0.2% 200 mg/100 mL (2 mg/mL) in 0.9% Sodium Chloride , 100 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1108-36

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 800 mcg/200 mL (4 mcg/mL) BUPivacaine HCl 0.1667% 333.4 mg/200 mL (1.667 mg/mL) in 0.9% Sodium Chloride 200 mL in 250 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1436-76

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ

AuroMedics Pharma

Class I - Dangerous

Discoloration; Hazy solution found in one vial instead of a clear solution.

Nov 12, 2019 Prescription Drugs View Details →

fentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1274-50

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 400 mcg/200 mL (2 mcg/mL) ROPivacaine HCl 0.1% 200 mg/200 mL (1 mg/mL) in 0.9% Sodium Chloride 200 mL CADD, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1441-76

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

LETS GEL KIT Convenience Pack (To prepare 100 mL LETS GEL), Contains: LETS Powders for Gel: Lidocaine Hydrochloride - 4 g, Ephinephrine Bitartrate - 180 mg, Tetracaine Hydrochloride - 500 mg, Sodium Metabisulfite - 75 mg, SuturaGel Methlcellulose Base; RX Only, For Prescription Compounding, Fagron, Inc., 2400 Pilot Knob Rd, St. Paul, MN 55120. NDC: 51552-1539-1

Fagron

Class I - Dangerous

Microbial contamination of non-sterile product.

Oct 31, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% Sodium Chloride Preservative Free 100 mL in 150 mL Bag, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1103-36

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 400 mcg/200 mL (2 mcg/mL) 0.1% ROPivacaine HCl 200 mg/200 mL (1 mg/mL) in 0.9% Sodium Chloride , 200 mL bag, Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1207-37

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 500 mcg/250 mL (2 mcg/mL) 0.125% BUPivacaine HCl 312.5 mg/250 mL (1.25 mg/mL) in 0.9% Sodium Chloride 250 mL Bag, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1105-37

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 1000 mcg/100 mL (10 mcg/mL) in 0.9% Sodium Chloride Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1092-36

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.125% 125 mg/100 mL (1.25 mg/mL) in 0.9% Sodium Chloride Preservative Free, 100 mL in 150 Bag, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1104-36

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

fentaNYL 1000 mcg/20 mL (50 mcg/mL) 20 mL in 20 mL Syringe Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1415-47

QuVa Pharma

Class I - Dangerous

Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

Nov 12, 2019 Prescription Drugs Nationwide View Details →

← Back to All Drugs Recalls